Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 137

1.

[Gastrointestinal bleeding associated with NSAIDs, antiplatelet therapy and anticoagulant agent].

Lanas A.

Gastroenterol Hepatol. 2012 Sep;35 Suppl 1:35-42. doi: 10.1016/S0210-5705(12)70032-8. Spanish.

PMID:
23018006
2.

Colonic diverticular hemorrhage associated with the use of nonsteroidal anti-inflammatory drugs, low-dose aspirin, antiplatelet drugs, and dual therapy.

Nagata N, Niikura R, Aoki T, Shimbo T, Kishida Y, Sekine K, Tanaka S, Watanabe K, Sakurai T, Yokoi C, Akiyama J, Yanase M, Mizokami M, Uemura N.

J Gastroenterol Hepatol. 2014 Oct;29(10):1786-93. doi: 10.1111/jgh.12595.

PMID:
24720424
3.

Strategies to reduce the GI risks of antiplatelet therapy.

Scheiman JM.

Rev Cardiovasc Med. 2005;6 Suppl 4:S23-31. Review.

PMID:
17710073
4.

Risk factors for gastrointestinal bleeding associated with low-dose aspirin.

Valkhoff VE, Sturkenboom MC, Kuipers EJ.

Best Pract Res Clin Gastroenterol. 2012 Apr;26(2):125-40. doi: 10.1016/j.bpg.2012.01.011. Review.

PMID:
22542151
5.

Low-Dose Aspirin and Non-steroidal Anti-inflammatory Drugs Increase the Risk of Bleeding in Patients with Gastroduodenal Ulcer.

Kawasaki K, Kurahara K, Yanai S, Kochi S, Fuchigami T, Matsumoto T.

Dig Dis Sci. 2015 Apr;60(4):1010-5. doi: 10.1007/s10620-014-3415-9. Epub 2014 Nov 1.

PMID:
25366148
6.

Risk of upper and lower gastrointestinal bleeding in patients taking nonsteroidal anti-inflammatory drugs, antiplatelet agents, or anticoagulants.

Lanas Á, Carrera-Lasfuentes P, Arguedas Y, García S, Bujanda L, Calvet X, Ponce J, Perez-Aísa Á, Castro M, Muñoz M, Sostres C, García-Rodríguez LA.

Clin Gastroenterol Hepatol. 2015 May;13(5):906-12.e2. doi: 10.1016/j.cgh.2014.11.007. Epub 2014 Nov 14.

PMID:
25460554
7.

Preventing recurrent upper gastrointestinal bleeding in patients with Helicobacter pylori infection who are taking low-dose aspirin or naproxen.

Chan FK, Chung SC, Suen BY, Lee YT, Leung WK, Leung VK, Wu JC, Lau JY, Hui Y, Lai MS, Chan HL, Sung JJ.

N Engl J Med. 2001 Mar 29;344(13):967-73.

8.

The risk of upper gastrointestinal bleeding in elderly users of aspirin and other non-steroidal anti-inflammatory drugs: the role of gastroprotective drugs.

Pilotto A, Franceschi M, Leandro G, Paris F, Niro V, Longo MG, D'Ambrosio LP, Andriulli A, Di Mario F.

Aging Clin Exp Res. 2003 Dec;15(6):494-9.

PMID:
14959953
9.

[Risk of gastrointestinal bleeding with aspirin and platelet antiaggregants].

Nardulli G, Lanas A.

Gastroenterol Hepatol. 2009 Jan;32(1):36-43. doi: 10.1016/j.gastrohep.2008.02.001. Epub 2008 Dec 31. Review. Spanish.

PMID:
19174098
10.

Risk factors for peptic ulcer bleeding in terms of Helicobacter pylori, NSAIDs, and antiplatelet agents.

Kang JM, Kim N, Lee BH, Park HK, Jo HJ, Shin CM, Lee SH, Park YS, Hwang JH, Kim JW, Jeong SH, Lee DH, Jung HC, Song IS.

Scand J Gastroenterol. 2011 Nov;46(11):1295-301. doi: 10.3109/00365521.2011.605468. Epub 2011 Aug 5.

PMID:
21815866
11.
12.
13.

Systematic review: Helicobacter pylori and the risk of upper gastrointestinal bleeding risk in patients taking aspirin.

Fletcher EH, Johnston DE, Fisher CR, Koerner RJ, Newton JL, Gray CS.

Aliment Pharmacol Ther. 2010 Oct;32(7):831-9. doi: 10.1111/j.1365-2036.2010.04415.x. Review.

14.

Systematic reviews of the clinical effectiveness and cost-effectiveness of proton pump inhibitors in acute upper gastrointestinal bleeding.

Leontiadis GI, Sreedharan A, Dorward S, Barton P, Delaney B, Howden CW, Orhewere M, Gisbert J, Sharma VK, Rostom A, Moayyedi P, Forman D.

Health Technol Assess. 2007 Dec;11(51):iii-iv, 1-164. Review.

15.

New look at antiplatelet agent-related peptic ulcer: an update of prevention and treatment.

Hsu PI.

J Gastroenterol Hepatol. 2012 Apr;27(4):654-61. doi: 10.1111/j.1440-1746.2012.07085.x.

PMID:
22283743
16.

Acute Middle Gastrointestinal Bleeding Risk Associated with NSAIDs, Antithrombotic Drugs, and PPIs: A Multicenter Case-Control Study.

Nagata N, Niikura R, Yamada A, Sakurai T, Shimbo T, Kobayashi Y, Okamoto M, Mitsuno Y, Ogura K, Hirata Y, Fujimoto K, Akiyama J, Uemura N, Koike K.

PLoS One. 2016 Mar 15;11(3):e0151332. doi: 10.1371/journal.pone.0151332. eCollection 2016.

17.

Gastrointestinal injury from NSAID therapy. How to reduce the risk of complications.

Lanas A.

Postgrad Med. 2005 Jun;117(6):23-8, 31. Review.

PMID:
16001765
18.

[Role of Helicobacter pylori infection and use of NSAIDs in the etiopathogenesis of upper gastrointestinal bleeding].

Sokić-Milutinović A, Krstić M, Popović D, Mijalković N, Djuranović S, Culafić Dj.

Acta Chir Iugosl. 2007;54(1):51-62. Serbian.

PMID:
17633863
19.

Risk of upper gastrointestinal bleeding associated with non-aspirin cardiovascular drugs, analgesics and nonsteroidal anti-inflammatory drugs.

Lanas A, Serrano P, Bajador E, Fuentes J, Sáinz R.

Eur J Gastroenterol Hepatol. 2003 Feb;15(2):173-8.

PMID:
12560762
20.

ACCF/ACG/AHA 2008 expert consensus document on reducing the gastrointestinal risks of antiplatelet therapy and NSAID use: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

Bhatt DL, Scheiman J, Abraham NS, Antman EM, Chan FK, Furberg CD, Johnson DA, Mahaffey KW, Quigley EM, Harrington RA, Bates ER, Bridges CR, Eisenberg MJ, Ferrari VA, Hlatky MA, Kaul S, Lindner JR, Moliterno DJ, Mukherjee D, Schofield RS, Rosenson RS, Stein JH, Weitz HH, Wesley DJ; American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents.

J Am Coll Cardiol. 2008 Oct 28;52(18):1502-17. doi: 10.1016/j.jacc.2008.08.002. No abstract available.

Supplemental Content

Support Center